NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder.
Neural mechanisms of psilocybin-assisted treatment for alcohol use disorder. is a funding opportunity from NEW YORK UNIVERSITY SCHOOL OF MEDICINE, up to 665785, closing August 31, 2029.
Aug 31, 2029
(1127d left)Overview
Preclinical and clinical research provides strong evidence that psilocybin and other 5-HT2A agonist/partial agonist psychedelics have antiaddictive effects. In a double-blind randomized controlled trial of psilocybin- assisted treatment for alcohol use disorder (AUD), administration of psilocybin resulted in robust…